438 related articles for article (PubMed ID: 23596048)
1. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Rajala HL; Eldfors S; Kuusanmäki H; van Adrichem AJ; Olson T; Lagström S; Andersson EI; Jerez A; Clemente MJ; Yan Y; Zhang D; Awwad A; Ellonen P; Kallioniemi O; Wennerberg K; Porkka K; Maciejewski JP; Loughran TP; Heckman C; Mustjoki S
Blood; 2013 May; 121(22):4541-50. PubMed ID: 23596048
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
[TBL] [Abstract][Full Text] [Related]
3. Somatic
Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
[TBL] [Abstract][Full Text] [Related]
4. Somatic STAT3 mutations in large granular lymphocytic leukemia.
Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
7. STAT5B
Klein K; Witalisz-Siepracka A; Maurer B; Prinz D; Heller G; Leidenfrost N; Prchal-Murphy M; Suske T; Moriggl R; Sexl V
Leukemia; 2019 Sep; 33(9):2336-2340. PubMed ID: 30967617
[No Abstract] [Full Text] [Related]
8. STAT5b in LGL leukemia--a novel therapeutic target?
Rajala HL; Mustjoki S
Oncotarget; 2013 Jun; 4(6):808-9. PubMed ID: 23868875
[No Abstract] [Full Text] [Related]
9. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.
Olson KC; Moosic KB; Jones MK; Larkin PMK; Olson TL; Toro MF; Fox TE; Feith DJ; Loughran TP
Cancer Med; 2020 Sep; 9(18):6533-6549. PubMed ID: 32710512
[TBL] [Abstract][Full Text] [Related]
10. Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.
Andersson E; Kuusanmäki H; Bortoluzzi S; Lagström S; Parsons A; Rajala H; van Adrichem A; Eldfors S; Olson T; Clemente MJ; Laasonen A; Ellonen P; Heckman C; Loughran TP; Maciejewski JP; Mustjoki S
Leukemia; 2016 May; 30(5):1204-8. PubMed ID: 26419508
[No Abstract] [Full Text] [Related]
11. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
[TBL] [Abstract][Full Text] [Related]
12. LGL leukemia and autoimmunity - the borderline between autoimmune disease and cancer is becoming blurred.
Savola P; Rajala H; Mustjoki S
Duodecim; 2016; 132(15):1328-35. PubMed ID: 29160632
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
[TBL] [Abstract][Full Text] [Related]
14. Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation.
Andersson EI; Rajala HL; Eldfors S; Ellonen P; Olson T; Jerez A; Clemente MJ; Kallioniemi O; Porkka K; Heckman C; Loughran TP; Maciejewski JP; Mustjoki S
Blood Cancer J; 2013 Dec; 3(12):e168. PubMed ID: 24317090
[TBL] [Abstract][Full Text] [Related]
15. LGL leukemia: from pathogenesis to treatment.
Lamy T; Moignet A; Loughran TP
Blood; 2017 Mar; 129(9):1082-1094. PubMed ID: 28115367
[TBL] [Abstract][Full Text] [Related]
16. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias.
Olson TL; Cheon H; Xing JC; Olson KC; Paila U; Hamele CE; Neelamraju Y; Shemo BC; Schmachtenberg M; Sundararaman SK; Toro MF; Keller CA; Farber EA; Onengut-Gumuscu S; Garrett-Bakelman FE; Hardison RC; Feith DJ; Ratan A; Loughran TP
Blood; 2021 Aug; 138(8):662-673. PubMed ID: 33786584
[TBL] [Abstract][Full Text] [Related]
17. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
[TBL] [Abstract][Full Text] [Related]
19. Clinical Study of the Relationship between Sjögren Syndrome and T-Cell Large Granular Lymphocytic Leukemia: Single-Center Experience.
Gorodetskiy V; Vasilyev V; Sidorova Y; Biderman B; Kupryshina N; Vagida M; Ryzhikova N; Sudarikov A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362126
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]